Abstract | OBJECTIVE: METHODS: Healthy Sprague-Dawley aged rats were randomly assigned into 4 groups: POCD group, nimodipine group, HS group, and nimodipine+HS group. Rats in POCD group received normal saline injection and then splenectomy 30min later under 1.8% isoflurane inhalation for 2h. In remaining groups, rats received injection of 1mg/kg nimodipine (i.p) and/or 4ml/kg 7.5% HS (i.v) and then splenectomy. Morris water maze test was performed before and after surgery. The hippocampus was harvested for the detection of neuronal apoptosis rate (AR), cytoplasmic calcium ([Ca2+]i), Bcl-2 and Bax mRNA expression and hippocampal neuronal ultrastructure. RESULTS: When compared with POCD group, the latency to escape, neuronal AR, [Ca2+]i, Bax mRNA expression and Bax/Bcl-2 ratio reduced dramatically, but the times of crossing the platform and Bcl-2 mRNA expression increased significantly (P<0.05) in nimodipine group, NS group and nimodipine+HS group. In addition, the latency to escape, neuronal AR, [Ca2+]i, Bax mRNA expression and Bax/Bcl-2 ratio reduced markedly, but the times of crossing the platform and Bcl-2 mRNA expression increased significantly in nimodipine+HS group as compared to nimodipine group and NS group (P<0.05). Hippocampal neuronal ultrastructure damage was observed in all 4 groups, but it was the mildest in nimodipine+HS group. CONCLUSION: Pre-treatment with both nimodipine and 7.5% HS exerts better protective effects, which is related to the inhibition of hippocampal neuronal apoptosis.
|
Authors | Zhang Qi, Yuan Tianbao, Li Yanan, Xin Xi, He Jinhua, Wang Qiujun |
Journal | Behavioural brain research
(Behav Brain Res)
Vol. 321
Pg. 1-7
(03 15 2017)
ISSN: 1872-7549 [Electronic] Netherlands |
PMID | 28017853
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Elsevier B.V. All rights reserved. |
Chemical References |
- Bax protein, rat
- Bcl2 protein, rat
- Neuroprotective Agents
- Proto-Oncogene Proteins c-bcl-2
- RNA, Messenger
- Saline Solution, Hypertonic
- bcl-2-Associated X Protein
- Nimodipine
|
Topics |
- Animals
- Apoptosis
(drug effects, physiology)
- Cognition Disorders
(etiology, pathology, physiopathology, prevention & control)
- Disease Models, Animal
- Drug Therapy, Combination
- Hippocampus
(drug effects, pathology, physiopathology)
- Male
- Maze Learning
(drug effects, physiology)
- Neurons
(drug effects, pathology, physiology)
- Neuroprotective Agents
(pharmacology)
- Nimodipine
(pharmacology)
- Postoperative Complications
(pathology, physiopathology, prevention & control)
- Proto-Oncogene Proteins c-bcl-2
(metabolism)
- RNA, Messenger
(metabolism)
- Random Allocation
- Rats, Sprague-Dawley
- Saline Solution, Hypertonic
(pharmacology)
- Splenectomy
- Time Factors
- bcl-2-Associated X Protein
(metabolism)
|